{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T18:39:41Z","timestamp":1793903981694,"version":"4.8.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,6]],"date-time":"2024-01-06T00:00:00Z","timestamp":1704499200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.ejso.2024.107953","type":"journal-article","created":{"date-parts":[[2024,1,5]],"date-time":"2024-01-05T22:14:47Z","timestamp":1704492887000},"page":"107953","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Active surveillance of diffuse-type tenosynovial giant cell tumors: A retrospective, multicenter cohort study"],"prefix":"10.1016","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0236-7338","authenticated-orcid":false,"given":"Geert","family":"Spierenburg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric L.","family":"Staals","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3406-6705","authenticated-orcid":false,"given":"Emanuela","family":"Palmerini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3660-774X","authenticated-orcid":false,"given":"Robert Lor","family":"Randall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3127-4912","authenticated-orcid":false,"given":"Steven W.","family":"Thorpe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5978-9400","authenticated-orcid":false,"given":"Jay S.","family":"Wunder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter C.","family":"Ferguson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Floortje G.M.","family":"Verspoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0390-1018","authenticated-orcid":false,"given":"Matthew T.","family":"Houdek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas M.","family":"Bernthal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart H.W.B.","family":"Schreuder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Gelderblom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9156-7656","authenticated-orcid":false,"given":"Michiel A.J.","family":"van de Sande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lizz","family":"van der Heijden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejso.2024.107953_bib1","series-title":"5th world health organization classification of tumours of soft tissue and bone","article-title":"Tenosynovial giant cell tumour","author":"de St Aubain Somerhausen","year":"2020"},{"issue":"8","key":"10.1016\/j.ejso.2024.107953_bib2","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.radcr.2019.05.013","article-title":"Histologically benign metastasizing tenosynovial giant cell tumor mimicking metastatic malignancy: a case report and review of literature","volume":"14","author":"Chen","year":"2019","journal-title":"Radiol Case Rep"},{"issue":"10","key":"10.1016\/j.ejso.2024.107953_bib3","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.3899\/jrheum.160816","article-title":"Tenosynovial giant cell tumor: incidence, prevalence, patient characteristics, and recurrence. A registry-based cohort study in Denmark","volume":"44","author":"Ehrenstein","year":"2017","journal-title":"J\u00a0Rheumatol"},{"issue":"6","key":"10.1016\/j.ejso.2024.107953_bib4","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1080\/17453674.2017.1361126","article-title":"Higher incidence rates than previously known in tenosynovial giant cell tumors","volume":"88","author":"Mastboom","year":"2017","journal-title":"Acta Orthop"},{"issue":"4","key":"10.1016\/j.ejso.2024.107953_bib5","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.clinthera.2016.03.008","article-title":"Patient-reported symptoms of tenosynovial giant cell tumors","volume":"38","author":"Gelhorn","year":"2016","journal-title":"Clin Therapeut"},{"issue":"1","key":"10.1016\/j.ejso.2024.107953_bib6","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1186\/s13023-021-01820-6","article-title":"The diffuse-type tenosynovial giant cell tumor (dt-TGCT) patient journey: a prospective multicenter study","volume":"16","author":"Bernthal","year":"2021","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"10.1016\/j.ejso.2024.107953_bib7","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1186\/s13023-021-01883-5","article-title":"Economic burden and health-related quality of life in tenosynovial giant-cell tumour patients in Europe: an observational disease registry","volume":"16","author":"Lopez-Bastida","year":"2021","journal-title":"Orphanet J Rare Dis"},{"issue":"5","key":"10.1016\/j.ejso.2024.107953_bib8","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1148\/rg.285085134","article-title":"Pigmented villonodular synovitis: radiologic-pathologic correlation","volume":"28","author":"Murphey","year":"2008","journal-title":"Radiographics"},{"issue":"3","key":"10.1016\/j.ejso.2024.107953_bib9","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1073\/pnas.0507321103","article-title":"A\u00a0landscape effect in tenosynovial giant-cell tumor from activation of CSF1 expression by a translocation in a minority of tumor cells","volume":"103","author":"West","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ejso.2024.107953_bib10","series-title":"Tenosynovial giant cell tumors (TGCT): molecular biology, drug targets and non-surgical pharmacological approaches","author":"Spierenburg","year":"2022"},{"issue":"7","key":"10.1016\/j.ejso.2024.107953_bib11","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1093\/annonc\/mdz124","article-title":"Surgery in reference centers improves survival of sarcoma patients: a nationwide study","volume":"30","author":"Blay","year":"2019","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejso.2024.107953_bib12","article-title":"Best clinical management of tenosynovial giant cell tumour (TGCT): a consensus paper from the community of experts","volume":"112","author":"Silvia","year":"2022","journal-title":"Cancer Treat Rev"},{"issue":"5","key":"10.1016\/j.ejso.2024.107953_bib13","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1080\/17453674.2016.1205168","article-title":"Arthroplasty for tenosynovial giant cell tumors","volume":"87","author":"Verspoor","year":"2016","journal-title":"Acta Orthop"},{"key":"10.1016\/j.ejso.2024.107953_bib14","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/S1470-2045(19)30100-7","article-title":"Surgical outcomes of patients with diffuse-type tenosynovial giant-cell tumours: an international, retrospective, cohort study","volume":"20","author":"Mastboom","year":"2019","journal-title":"Lancet Oncol"},{"issue":"19","key":"10.1016\/j.ejso.2024.107953_bib15","doi-asserted-by":"crossref","first-page":"4901","DOI":"10.1002\/cncr.26529","article-title":"Long-term outcome of the treatment of high-risk tenosynovial giant cell tumor\/pigmented villonodular synovitis with radiotherapy and surgery","volume":"118","author":"Griffin","year":"2012","journal-title":"Cancer"},{"issue":"7","key":"10.1016\/j.ejso.2024.107953_bib16","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1302\/0301-620X.100B7.BJJ-2017-0867.R3","article-title":"Inconclusive benefit of adjuvant (90)Yttrium hydroxyapatite to radiosynovectomy for diffuse-type tenosynovial giant-cell tumour of the knee","volume":"100-b","author":"Gortzak","year":"2018","journal-title":"Bone Joint Lett J"},{"issue":"4","key":"10.1016\/j.ejso.2024.107953_bib17","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1302\/0301-620X.97B4.34907","article-title":"The effect of surgical synovectomy and radiotherapy on the rate of recurrence of pigmented villonodular synovitis of the knee: an individual patient meta-analysis","volume":"97-b","author":"Mollon","year":"2015","journal-title":"Bone Joint Lett J"},{"issue":"25","key":"10.1016\/j.ejso.2024.107953_bib18","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.2217\/fon-2020-0307","article-title":"ENLIVEN study: pexidartinib for tenosynovial giant cell tumor (TGCT)","volume":"16","author":"Tap","year":"2020","journal-title":"Future Oncol"},{"issue":"4","key":"10.1016\/j.ejso.2024.107953_bib19","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1097\/CCO.0000000000000853","article-title":"Treatment updates on tenosynovial giant cell tumor","volume":"34","author":"Palmerini","year":"2022","journal-title":"Curr Opin Oncol"},{"issue":"22","key":"10.1016\/j.ejso.2024.107953_bib20","doi-asserted-by":"crossref","first-page":"4934","DOI":"10.1158\/1078-0432.CCR-22-1898","article-title":"Interactions in CSF1-driven tenosynovial giant cell tumors","volume":"28","author":"van","year":"2022","journal-title":"Clin Cancer Res"},{"issue":"1s","key":"10.1016\/j.ejso.2024.107953_bib21","doi-asserted-by":"crossref","first-page":"S91","DOI":"10.1016\/j.otsr.2016.11.002","article-title":"Localized and diffuse forms of tenosynovial giant cell tumor (formerly giant cell tumor of the tendon sheath and pigmented villonodular synovitis)","volume":"103","author":"Gouin","year":"2017","journal-title":"Orthop Traumatol Surg Res"},{"key":"10.1016\/j.ejso.2024.107953_bib22","doi-asserted-by":"crossref","DOI":"10.1093\/oncolo\/oyad011","article-title":"Tenosynovial giant cell tumor observational platform project (TOPP) registry: a 2-year analysis of patient-reported outcomes and treatment strategies","author":"Palmerini","year":"2023","journal-title":"Oncol"},{"key":"10.1016\/j.ejso.2024.107953_bib23","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.900010","article-title":"Randomized placebo-controlled double-blind phase II study of zaltoprofen for patients with diffuse-type and unresectable localized tenosynovial giant cell tumors: the REALIZE study","volume":"12","author":"Takeuchi","year":"2022","journal-title":"Front Oncol"},{"issue":"11","key":"10.1016\/j.ejso.2024.107953_bib24","doi-asserted-by":"crossref","first-page":"2852","DOI":"10.1093\/annonc\/mdx484","article-title":"Improved survival using specialized multidisciplinary board in sarcoma patients","volume":"28","author":"Blay","year":"2017","journal-title":"Ann Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2024.107953_bib25","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/01.PHM.0000150794.33166.3A","article-title":"Pigmented villonodular synovitis: an uncommon presentation of anterior hip pain","volume":"84","author":"Spanier","year":"2005","journal-title":"Am J Phys Med Rehabil"},{"issue":"2","key":"10.1016\/j.ejso.2024.107953_bib26","doi-asserted-by":"crossref","first-page":"174","DOI":"10.11124\/jbisrir-2016-2270","article-title":"The experience of adults who choose watchful waiting or active surveillance as an approach to medical treatment: a qualitative systematic review","volume":"14","author":"Rittenmeyer","year":"2016","journal-title":"JBI Database System Rev Implement Rep"},{"key":"10.1016\/j.ejso.2024.107953_bib27","author":"Turalio"},{"issue":"16","key":"10.1016\/j.ejso.2024.107953_bib28","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1007\/s40265-019-01210-0","article-title":"Pexidartinib: first approval","volume":"79","author":"Lamb","year":"2019","journal-title":"Drugs"},{"issue":"11","key":"10.1016\/j.ejso.2024.107953_bib29","article-title":"Management of tenosynovial giant cell tumor: a neoplastic and inflammatory disease","volume":"4","author":"Healey","year":"2020","journal-title":"J\u00a0Am Acad Orthop Surg Glob Res Rev"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798324000052?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798324000052?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:50:36Z","timestamp":1760061036000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798324000052"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["S0748798324000052"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2024.107953","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Active surveillance of diffuse-type tenosynovial giant cell tumors: A retrospective, multicenter cohort study","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2024.107953","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"107953"}}